Year-end Sale % OFF 
Abstract
Analgesics of the non-steroidal antiinflammatory group (NSAID) are classified as "peripheral analgesics" and act via cyclooxygenase inhibition, reducing the biosynthesis of peripheral prostaglandins (PGs). However, there has been some evidence that NSAIDs also reduce the nociceptive and hyperalgesic stimuli, either via inhibition of central cyclooxygenase [1], or via inhibition of Substance P (SP), another known mediator of pain at the spinal level [2]. This study was undertaken to investigate whether the antinociceptive effects of NSAIDs in the phenylbenzoquinone (PBQ)-induced writhing assay in mice had a central component, at either a supraspinal or spinal site, and for their effect against intrathecally administered SP.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
